DRMA
Dermata Therapeutics, Inc. - Common Stock (DRMA)
$69
About Dermata Therapeutics, Inc. - Common Stock (DRMA)
Dermata Therapeutics, Inc. is a clinical-stage medical dermatology company that focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin diseases. Its product pipeline includes DMT310, DMT400, and DMT410. The company was founded by David F. Hale and Gerald T. Proehl on December 8, 2014 and is headquartered in San Diego, CA.
Details
Daily high
$0.72
Daily low
$0.65
Price at open
$0.71
52 Week High
$5.00
52 Week Low
$0.65
Market cap
4.4M
Dividend yield
0.00%
Volume
133,231
Avg. volume
77,907
P/E ratio
-.09
Dermata Therapeutics, Inc. - Common Stock News
Details
Daily high
$0.72
Daily low
$0.65
Price at open
$0.71
52 Week High
$5.00
52 Week Low
$0.65
Market cap
4.4M
Dividend yield
0.00%
Volume
133,231
Avg. volume
77,907
P/E ratio
-.09